3 results
Approved WMORecruiting
* To decrease mortality in MS-LCH by an early switch of patients with risk organ involvement, who do not respond to front-line therapy, to a more intensive treatment (Stratum III or Stratum IV).* To reduce reactivation rates and permanent…
Approved WMOCompleted
To develop a PKPD dexmedetomidine model, and to assess the effect of continuous auditory stimulation on dexmedetomidine pharmacodynamics.
Study of a novel implantable device to generate an autologous vascular graft for hemodialysis access
The objective of the study is to assess the use of the Tissue Capsule for AV grafting in renal failure patients and testing these AV grafts for hemodialysis access.